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David K WhynesAbstract
Background: The EQ-5D health-related quality of life instrument comprises a health state classification (health
problems by severity in five domains), followed by an evaluation using a visual analogue scale (VAS). Despite the
EQ-5D’s use in health technology assessment and as a patient-reported outcome measure (PROM), the
correspondence between the two parts of the instrument remains ill-understood. In this paper, we consider
whether the association between health state classification and VAS score might vary by medical condition.
Methods: EQ-5D data collected for studies of patients in four different clinical conditions or circumstances (stroke,
low back pain, colposcopic investigation or cytological surveillance) were pooled to generate a sample of 3,851
patient records. VAS scores were regressed on reported problem severities, with the inclusion of intercept and
slope dummy variables specific to condition.
Results: The regression model achieved a goodness-of-fit of 0.54. Given its structure and the significance of the
coefficients, the proportion of VAS scores which differed by condition for the same health state varied between
33.3 and 88.5 per cent of possible states.
Conclusions: Many of the patients with different medical conditions or in receipt of different interventions
recorded different VAS valuations, in spite of ostensibly being in the same EQ-5D-defined health states. By
implication, it is probable that the same state-to-state change would by valued differently by patients experiencing
different conditions.
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measuresIntroduction
The EQ-5D is a well-established and widely-used generic
instrument for assessing health-related quality of life
(HRQL). It is a two-part questionnaire, designed for
self-completion. In the first part, the respondent describes
his or her prevailing state of health in terms of perceived
problem severities for five domains. These domains are
limitations on mobility, capacity for self-care, ability to
conduct usual activities, pain & discomfort and anxiety
& depression, in that order. Three severity descriptions
are available within each domain in the traditional version
of the instrument (EQ-5D-3L), namely, none, moderate
and severe/extreme (coded 1 through 3, respectively).Correspondence: david.whynes@nottingham.ac.uk
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reproduction in any medium, provided the orThis descriptive system accommodates 243 possible
health states, each defined as a different vector or profile,
ranging from 11111 (no problems in any domain) to
33333 (severe problems in all domains). In the second
part of the instrument, the respondent evaluates his or
her prevailing state of health by indicating a position on a
visual analogue scale (VAS). This is a vertical, calibrated,
line, anchored at 0, the “worst health state imaginable ”,
and at 100, the “best health state imaginable ” [1].
The principal use of the EQ-5D instrument to date has
been in health technology assessment (HTA); indeed, the
UK’s influential National Institute for Health and Clinical
Excellence has declared the EQ-5D to be “the preferred
measure of HRQL in adults” [2] p. 38. For the purposes
of cost utility HTA, the first (descriptive) part of theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(evaluative) part. This is because HTA conventions in
most countries [3] dictate that, whilst the health effects
of interventions during clinical trials should be assessed
using the health state descriptions made by the participat-
ing individuals, the values of those states should derive
from public or social, rather than individual, judgements
[4]. These social health state utilities are obtained from
independent studies which aggregate the opinions of
members of general populations into state-specific “index
scores”, anchored at 1 (EQ-5D state 11111) and 0 (dead).
As EQ-5D VAS results have had little relevance in
HTA, the relationship between individuals’ descriptive
profiles and their corresponding VAS scores has not been
extensively researched. Only a few regression studies have
been undertaken, predicting VAS scores from reported
problem severities by domain, coded as binary dummy
variables. These studies confirm the intuition that subjects
who report more health problems at greater severities
tend to indicate poorer HRQL in the form of lower
VAS scores. For example, a UK analysis of a large sample
of pooled records for surgical procedures reported that
“the binary variable coefficients are all in the expected
direction and are highly statistically significant. More-
over, they are consistent in each dimension, so that the
coefficients on level 3 are all higher than the coefficients
of level 2. The differences between the level 2 and level
3 scores are all significant” [5] p. 16-17. Such analyses
also suggest that problem severity variations in the five
domains are, of themselves, insufficient to explain VAS
scores fully [6-8].
A new role for the EQ-5D raises further concern over
the absence of investigations of the association between
profiles and VAS scores. Since 2009, the National Health
Service (NHS) in England has been collating and pub-
lishing data from a suite of “before and after” patient-
reported outcome measures (PROMs) [9]. PROMs are
intended to facilitate comparisons of provider perform-
ance and of patient benefit from services. Although the
PROMs include both components of the EQ-5D, the
performance of the VAS was excluded from appraisal
of the pre-implementation pilot study [10]. Presently
limited to four types of elective surgery (hip, knee, hernia
repair and varicose veins), there exists an explicit intention
to “extend PROMs across the NHS wherever practicable”
[11] p. 14. Assuming that such an extension were to occur,
published VAS and index scores would become available
and might be used for comparison across different con-
ditions, despite the validity of any such comparison
remaining un-established. The potential problem is not
confined to England, as other countries, including Sweden
[12] and Canada [13], have indicated an interest in pub-
lishing EQ-5D results as part of their own PROMs
packages.The EQ-5D aims to be a “non-disease-specific instru-
ment for describing and valuing health-related quality of
life” [14] p. 337, and it was the promise of generality which
made the instrument attractive as a PROM [15]. For this
aspiration to be realised, however, it is necessary to sup-
pose that the association between EQ-5D profile and VAS
score does not vary systematically by medical condition or
circumstances. Were the converse to be the case, it would
follow that VAS results are not necessarily comparable
across conditions or interventions, even when subjects
are ostensibly in the same health states. In this paper, we
consider the supposition as a hypothesis and investigate
the association between VAS scores and health states
amongst subjects experiencing different interventions.
Method
The data for the investigation constituted a convenience
sample, constructed by pooling EQ-5D records for partici-
pants in several controlled clinical trials of different condi-
tions. The data comprised four sub-samples, as follows:
i) Men and women with a mean (SD) age of 56.5 (9.8)
years, undergoing epidural steroid treatment for
chronic low back pain, recorded regularly over a
period of six months [16,17].
ii) Men and women with a mean (SD) age of 69.9
(11.4) years, in recovery following a stroke and
recorded at approximately three months
post-event [18].
iii) Women of mean (SD) age 35.2 (10.7) years, being
followed up after a colposcopic examination
following abnormal cervical cytology. These women
would have experienced excision or ablation of
abnormalities as necessary, and were recorded at
approximately nine months post-event [19,20].
iv) Women of mean (SD) age 35.1 (10.7) years, with no
specific medical conditions and receiving no active
treatment. These women were under routine
cytological surveillance following abnormal
cytology, which had occurred up to one year prior
to HRQL measurement [19,20].
All subjects had completed the EQ-5D-3L version of
the questionnaire. Details of patients characteristics
and methods of data collection appear in the sources
cited. Some of the patients in the original stroke study
had been recruited outside the UK but their records
were omitted from this analysis, as there are grounds
for believing that EQ-5D responses vary geographically
[21]. The other studies had been conducted with UK
subjects only.
All statistical analyses employed SPSS version 20.
One-way analysis of variance was conducted to establish
whether mean VAS and index scores differed between
Table 1 EQ-5D data characteristics, by data set
EQ-5D severity level,%
Domain 1 2 3 Mean 95% CIs
Low back pain (n = 903)
Mobility 5.2 93.3 1.4
Self care 36.0 62.1 1.9
Usual activities 6.7 81.8 11.5
Pain & discomfort 3.3 68.7 28.0
Anxiety & depression 42.8 46.8 10.5
VAS score 49.3 47.8 – 50.8
Index score 0.405 0.384 – 0.426
Stroke (n = 655)
Mobility 93.5 6.4 0.1
Self care 98.1 1.9 0.0
Usual activities 90.3 9.1 0.6
Pain & discomfort 75.9 22.3 1.8
Anxiety & depression 66.8 31.1 2.0
VAS score 66.0 64.3 – 67.7
Index score 0.571 0.545 – 0.596
Cytological surveillance (n = 1137)
Mobility 93.5 6.4 0.1
Self care 98.1 1.9 0.0
Usual activities 90.3 9.1 0.6
Pain & discomfort 75.9 22.3 1.8
Anxiety & depression 66.8 31.1 2.0
VAS score 79.6 78.6 – 80.6
Index score 0.885 0.874 – 0.896
Colposcopy (n = 1156)
Mobility 95.1 4.8 0.2
Self care 99.0 1.0 0.0
Usual activities 91.4 8.1 0.5
Pain & discomfort 78.7 20.0 1.2
Anxiety & depression 70.0 27.7 2.3
VAS score 81.7 80.8 – 82.6
Index score 0.896 0.886 – 0.906
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using Potthoff regression analysis [22], which establishes
whether a relationship between a criterion variable and
predictor variables differs across values of a categorical
variable. The model to be estimated is
Y ¼ aþ b1Xþ b2Dþ b3DX
where Y is the VAS score. X is a vector of ten predictor
variables coded as 0/1 binary dummy variables. These are
the presence of level 2 and of level 3 health problems for
each of the five EQ-5D domains, with problems at level 1
being the reference categories. D is a vector comprising
binary dummy variables to connote three of the four
different sub-samples. The surveillance group was chosen
as the reference category, on the grounds that patients
in this group had been in receipt of the least amount of
formal treatment. Finally, D*X is a vector of thirty interac-
tions between each of the domain/severity variables and
each of the conditions/interventions. Significant b2 or b3
coefficients in the regression model would contradict the
primary hypothesis; specifically, one or more significant b2
coefficients would support the existence of different inter-
cepts in the VAS-determining equation for those condi-
tions, whereas significant b3 coefficients would support
the existence of differential slopes. The regression model
was fitted using stepwise regression.
Results
A total of 3,851 records were analysed. Table 1 displays
the characteristics of the four component data sets,
arranged by increasing mean VAS score for each set.
Analysis of variance indicated that all four mean VAS
scores were significantly different from one another (F
(3,3848) = 594.8, p < 0.01). The index scores of the four
sets differed significantly also, with the exception of
those for colposcopy and surveillance (F(3,3848) = 893.1,
p < 0.01). Of the four sets, those for surveillance and
colposcopy displayed the greatest similarity in terms of
EQ-5D profile, with the surveillance group recording
slightly fewer problems at level 1 in each domain. Com-
pared with these two data sets, those for stroke and for
back pain included substantially more problems beyond
level 1 in all domains. Subjects in these two sub-samples
were considerably older than those in the colposcopy and
surveillance sub-samples, with the stroke patients being
older on average than the back pain patients. Problems
with mobility and pain & discomfort were less frequently
reported in the stroke sample than in the back pain
sample. In the full sample 113 different health states were
represented.
Table 2 presents the regression model (adjusted R2 =
0.54) which possessed a number of characteristics of in-
terest. First, neither of the coefficients for the level 2 andthe level 3 variable in the “capacity for self care” domain
achieved statistical significance. Second, and irrespective
of intervention, the relative magnitudes of the estimated
coefficients of levels 2 and 3 for the remaining domains
were consistent with intuition, in that greater problem
severity was associated with lower VAS score. Third,
none of the coefficients on the intercept dummies (b2)
achieved statistical significance at 5 per cent. Fourth, as
regards the slope dummies (b3), moderate limitations on
usual activities for women following colposcopy exerted
a greater negative effect on VAS score, compared with
the reference group (surveillance). For those with low
Table 2 Regression results
EQ-5D domain Severity level b SE p =
Constant 87.1 0.4 < 0.01
Mobility 2 −4.7 1.1 < 0.01
Mobility 3 −10.1 2.5 < 0.01
Usual activities 2 −11.5 1.0 < 0.01
Usual activities 3 −17.2 1.4 < 0.01
Pain & discomfort 2 −3.9 0.8 < 0.01
Pain & discomfort 3 −18.5 2.9 < 0.01
Anxiety & depression 2 −11.8 0.7 < 0.01
Anxiety & depression 3 −30.9 2.4 < 0.01
Interaction terms (D*X)
Colposcopy Usual activities 2 5.5 1.8 < 0.01
Back pain Pain & discomfort 2 −11.7 1.3 < 0.01
Back pain Pain & discomfort 3 −11.4 3.2 < 0.01
Back pain Anxiety & depression 2 7.3 1.3 < 0.01
Back pain Anxiety & depression 3 22.2 3.1 < 0.01
Stroke Pain & discomfort 3 9.1 4.3 0.03
Stroke Anxiety & depression 3 14.2 3.8 < 0.01
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discomfort at levels 2 and 3 produced significantly lower
VAS scores, whereas anxiety & depression at these levels
were associated with higher VAS scores. For stroke
patients in comparison with the reference group, both
severe pain & discomfort and severe anxiety & depres-
sion were associated with smaller negative effects on
VAS scores.
Insignificant coefficients for the intercept dummies
(b2) imply that the predicted mean VAS score at health
state 11111 is the same for all four conditions, namely,
the constant term. However, significant coefficients on
at least some of the slope dummies mean that, for
many other health states as described by the EQ-5D, the
predicted VAS score must vary by condition. Evaluating
the estimated regression equation for vector 22222 pro-
duces mean VAS scores of 50.8 for low back pain, 55.2 for
surveillance and for stroke, and 60.7 for colposcopy. The
predicted scores for vector 33333 are 10.5 for surveillance
and colposcopy, 21.3 for back pain, and 33.7 for stroke.
Of the 243 EQ-5D states which any respondent could
possibly occupy, 81 (33.3 per cent) would have a severity
level of 2 for “usual activities”. Given the model’s struc-
ture, therefore, the VAS scores for the colposcopy group
would differ from those of the reference group for these
81 states. By the same token, the scores for the stroke
and low back pain groups would differ for 135 and 215
states (55.6 and 88.5 per cent, respectively), compared
against the reference. The scores for the stroke and back
pain groups would, between themselves, also differ for
215 (88.5 per cent) of states.The estimated regression model indicates that the mar-
ginal impact of a change in health state on VAS score
would, for many such changes, differ by condition. By way
of example, and based on the calculation above, a change
from health state vector 33333 to vector 22222 would
improve VAS scores by 21.5, 29.5, 44.7 and 50.2 for
stroke, back pain, surveillance and colposcopy patients,
respectively. At the domain level, and according to the
coefficients presented in Table 2, a decrease in severity
from level 2 to level 1 in the pain & discomfort domain
would entail an increase of 3.9 in VAS score for the
surveillance group. For the low back pain group, however,
the improvement would register an additional increase
of 11.7, or 15.6 in total. Similarly, a pain & discomfort
severity reduction from level 3 to level 2 would result
in the mean VAS score being 14.6 higher amongst the
colposcopy group but only 5.5 higher for the stroke
group. If anxiety & depression fell from severity level 3 to
level 2, the mean VAS score would rise by 19.0 according
to the colposcopy patients but by 4.9 according to the
stroke patients. An improvement from level 2 to level 1
would imply an increase of 4.5 in VAS score for the low
back pain group but of 11.8 for the surveillance group.
Discussion
A literature on the association between EQ-5D VAS
scores and health state descriptions does exist, although
in a context quite different from that of the present
investigation. In the past, the VAS has been employed
to establish index scores, rather than to self-evaluate
HRQL per se. Respondents from general populations
have been asked to consider hypothetical health states
and to associate a VAS score with each [23]. The average
valuations of hypothetical states made by large numbers
of individuals currently in no particular actual state
have become, in effect, social health state utilities. It was
observed at an early stage of the EQ-5D’s development
that when respondents actually existed in the health
state which they had been asked to value, their valuations
differed significantly from those for whom the state
was hypothetical [24,25]. The observed discrepancies
between patient and public values stimulated debate
over both whose opinions were the most appropriate for
HTA purposes [26] and the validity of using the VAS to
elicit social preferences [27].
In spite of the difference in context, two of the social
valuation studies provide some support for our findings.
First, the magnitude of the divergence between patient
VAS valuations of real states and population VAS values
for those states considered hypothetically, has been shown
to vary by medical condition [28]. This particular result
also contradicts the hypothesis under investigation,
namely, that patient VAS scores for any particular EQ-5D
health profile are not condition-specific. Second, a study
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domain concluded that, compared to respondents who
were valuing hypothetical states, those valuing the states
which they were actually experiencing attributed a far
lower significance to the capacity for self-care [29]. Our
subjects who were valuing real states also found the
capacity for self-care domain insignificant (Table 2).
The principal limitation of this study lies in its data.
These were derived from trial-based economic evaluations
in which the author participated and which were readily
available. Convenience rather than premeditated design
influenced the selection of records and, scientifically,
the data are less-than-perfect as a basis for testing the
hypothesis. For example, records of a proportion of the
stroke patients were completed by proxies, and the back
pain sub-sample comprised repeated measures whilst
the remainder did not. Sequential evaluation of health
states is prone to individual subject bias although none
was identified in the original studies, and VAS and index
scores were correlated over time [17]. That having been
said, inconsistencies in repeated VAS measures have
been identified; for example, a foot surgery study reported
a significant improvement of 0.2 in EQ-5D index scores at
six months whilst detecting no change in VAS scores [30].
Women were more heavily represented in the sample
than men, with two sets including data for women only.
We cannot exclude the possibility, therefore, that the ob-
served effect should be ascribed to sex rather than to the
medical conditions themselves. Opposing this possibility,
(i) none of the previous studies relating VAS response to
health profile reported a sex effect, (ii) regression models
using both the low back pain data and the stroke data
separately failed to produce significant coefficients for
the sex of respondent. In similar vein, the considerable
age differences between sub-samples raises the possibility
that differential response in VAS scoring might be age-
rather than condition-related. Distinguishing the effect
would prove difficult in this sample, in view of the strong
association between sub-sample age and condition.
In view of the new importance attached to VAS scores,
further research would seem imperative. Ideally, the
hypothesis would be investigated using purposefully-
collected data including more variables. Two classes of
candidate for inclusion would be, first, health domains
which are absent from the EQ-5D but present in other
HRQL instruments, domains such as sleep, memory and
energy & fatigue [8] and, second, measures of psycho-
logical disposition which have been shown to influence
self-perceived health independently of actual health [31,32].
Even so, and in spite of the idiosyncrasies of the data,
the coefficient of determination for the Table 2 model
was considerably beyond the 0.24-0.32 range obtained in
previous regression models [5-7] where different medical
conditions had not been distinguished.Conclusions
The results call into question the proposition that pa-
tients in the same EQ-5D-defined health state but with
different medical conditions (or in receipt of different
interventions) necessarily evaluate the state similarly. The
regression model supports the possibility that a given
change between two EQ-5D-defined health states could
produce different changes in VAS scores for different
medical conditions and interventions. It follows that
EQ-5D VAS scores published as PROMS may not be
consistent across different conditions or interventions.
Abbreviations
HRQL: Health-related quality of life; HTA: Health technology assessment;
NHS: National health service; PROM: Patient-reported outcome measure;
VAS: Visual analogue scale.
Competing interests
The author declares that he has no competing interests.
Received: 5 March 2013 Accepted: 9 September 2013
Published: 13 September 2013
References
1. Rabin R, Oemar M, Oppe M, on behalf of the EuroQoL Group: EQ-5D-3L user
guide. 4th edition. Rotterdam: EuroQoL Group; 2011.
2. National Institute for Health and Clinical Excellence: Guide to the methods of
technology appraisal. London: NICE; 2008.
3. Sorenson C, Drummond M, Kanavos P: Ensuring value for money in health
care: the role of health technology assessment in the European Union.
Copenhagen: World Health Organisation; 2008.
4. Benzer M: Independence in dependence: health technology assessment, quality
of life, and the position of the patient. London: Centre for Analysis of Risk
and Regulation, London School of Economics and Political Science; 2013.
5. Feng Y, Parkin D, Devlin NJ: Assessing the performance of the EQ-VAS in the
NHS PROMs programme (Research Paper 12/01). London: Office of Health
Economics; 2012.
6. Jelsma J, Ferguson G: The determinants of self-reported health-related
quality of life in a culturally and socially diverse South African
community. Bull World Health Organ 2004, 82:206–212.
7. Whynes DK: Correspondence between EQ-5D health state classifications
and EQ VAS scores. Health Qual Life Outcomes 2008, 6:94.
8. Perneger TV, Courvoisier DS: Exploration of health dimensions to be
included in multi-attribute health-utility assessment. Int J Qual Health
Care 2011, 23:52–59.
9. Health & Social Care Information Centre: Provisional monthly patient reported
outcome measures (PROMs) in England: a guide to PROMs methodology. 5th
edition. Leeds: H&SCIC; 2013.
10. Browne J, Jamieson L, Lawsey J, van der Meulen J, Black N, Cairns J,
Lamping D, Smith S, Copley L, Horrockes J: Patient Reported Outcome
Measures (PROMs) in elective surgery: report to the Department of Health.
London: Health Services Research Unit, London School of Hygiene &
Tropical Medicine; 2007.
11. Department of Health: Equity and excellence: liberating the NHS (Cm 7881).
Norwich: The Stationery Office; 2010.
12. Rolfson O, Kärrholm J, Dahlberg LE, Garellick G: Patient-reported outcomes
in the Swedish hip arthroplasty register. J Bone Joint Surg 2011,
93-B:867–875.
13. Bryan S, Broesch J, Dalzell K, Davis J, Dawes M, Doyle-Waters MM, Lewis S,
McGrail K, McGregor MJ, Murphy JM, Sawatzky R: What are the most effective
ways to measure patient health outcomes of primary health care integration
through PROM (Patient Reported Outcome Measurement) instruments?.
Vancouver, BC: Centre for Clinical Epidemiology & Evaluation; 2013.
14. Rabin R, De Charro F: EQ-5D: a measure of health status from the
EuroQol group. Ann Med 2001, 33:337–343.
15. Devlin NJ, Parkin D, Browne J: Patient-reported outcome measures in the
NHS: new methods for analysing and reporting EQ-5D data. Health Econ
2010, 19:886–905.
Whynes Health and Quality of Life Outcomes 2013, 11:155 Page 6 of 6
http://www.hqlo.com/content/11/1/15516. Whynes DK, McCahon RA, Ravenscroft A, Hardman J: Cost effectiveness of
epidural steroid injections to manage chronic lower back pain.
BMC Anesthesiol 2012, 12:26.
17. Whynes DK, McCahon RA, Ravenscroft A, Hodgkinson V, Evley R, Hardman
JG: Responsiveness of the EQ-5D health-related quality-of-life instrument
in assessing low back pain. Value Health 2013, 16:124–132.
18. Whynes DK, Sprigg N, Selby J, Berge E, Bath PM, for the ENOS Investigators:
Testing for differential item functioning within the EQ-5D. Med Decis
Making 2013, 33:252–260.
19. TOMBOLA Group: Cytological surveillance compared with immediate
referral for colposcopy in management of women with low grade
cervical abnormalities: multicentre randomised controlled trial.
Br Med J 2009, 339:b2546.
20. TOMBOLA Group: Options for managing low grade cervical abnormalities
detected at screening: cost effectiveness study. Br Med J 2009, 339:b2549.
21. Bailey H, Kind P: Preliminary findings of an investigation into the
relationship between national culture and EQ-5D value sets. Qual Life Res
2010, 19:1145–1154.
22. Potthoff RF: Statistical aspects of the problem of biases in psychological tests
(Institute of Statistics Mimeo Series No 479). Chapel Hill, NC: Department of
Statistics, University of North Carolina; 1966.
23. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J,
Buxton M, Dolan P, Kind P, Krabbe P, et al: A single European currency for
EQ-5D health states. results from a six-country study. Eur J Health Econ
2003, 4:222–231.
24. Dolan P: The effect of experience of illness on health state valuations.
J Clin Epidemiol 1996, 49:551–564.
25. McPherson K, Myers J, Taylor WJ, McNaughton HK, Weatherall M:
Self-valuation and societal valuations of health state differ with disease
severity in chronic and disabling conditions. Med Care 2004, 42:1143–1151.
26. Gandjour A: Theoretical foundation of patient v. population preferences
in calculating QALYs. Med Decis Making 2010, 30:E57–E63.
27. Parkin D, Devlin N: Is there a case for using visual analogue scale
valuations in cost-utility analysis? Health Econ 2006, 15:653–664.
28. Mann R, Brazier JE, Tsuchiya A: A comparison of patient and general
population weightings of EQ-5D dimensions. Health Econ 2009,
18:363–372.
29. Rand-Hendriksen K, Augestad LA, Kristiansen IS, Stavem K: Comparison of
hypothetical and experienced EQ-5D valuations: relative weights of the
five dimensions. Qual Life Res 2012, 21:1005–1012.
30. Maher AJ, Kilmartin TE: An analysis of Euroqol EQ-5D and Manchester
Oxford foot questionnaire scores six months following podiatric surgery.
J Foot Ankle Res 2012, 5:17.
31. Goodwin R, Engstrom G: Personality and the perception of health in the
general population. Psychol Med 2002, 32:325–332.
32. Kostka T, Jachimowicz V: Relationship of quality of life to dispositional
optimism, health locus of control and self-efficacy in older subjects
living in different environments. Qual Life Res 2010, 19:351–361.
doi:10.1186/1477-7525-11-155
Cite this article as: Whynes: Does the correspondence between EQ-5D
health state description and VAS score vary by medical condition?.
Health and Quality of Life Outcomes 2013 11:155.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
